Aims−Duchenne muscular dystrophy (DMD), a degenerative pathology of skeletal muscle, also induces cardiac failure and arrhythmias due to a mutation leading to the lack of the protein dystrophin. In cardiac cells, the subsarcolemmal localization of dystrophin is thought to protect the membrane from mechanical stress. The absence of dystrophin results in an elevated stress-induced Ca 2+ influx due to the inadequate functioning of several proteins, such as stretch-activated channels (SACs). Our aim was to investigate whether transient receptor potential vanilloid channels type 2 (TRPV2) form subunits of the dysregulated SACs in cardiac dystrophy.
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Introduction Duchenne muscular dystrophy (DMD) is a X-linked degenerative pathology of skeletal muscle, affecting 1 in 3"500 male births. Initially, this progressive disease causes muscle weakness and an impaired mobility requiring a wheelchair by 8-12 years of age. Subsequently, DMD is responsible for the slow development of respiratory failure. Medical advances, such as therapies for respiration support, have prolonged the life expectancy of patients to around 25 years. However, cardiac muscle manifestations are present in essentially all patients by 20 years of age. The heart develops a dilated cardiomyopathy (DCM) resulting in cardiac failure and arrhythmias causing the death of ~20% of all patients. 1 DMD results from a mutation in the Dys gene located on the X chromosome. This genetic alteration is responsible for the absence of the protein dystrophin. 2 Dystrophin is a rod-shaped protein expressed in muscle fibers. In cardiomyocytes, its subsarcolemmal and sarcomeric localization along the T-tubule network is essential to maintain the membrane architecture. 3 Dystrophin is associated with the dystrophin-glycoprotein complex (DGC) which is composed of several transmembrane proteins such as α-, β-dystroglycans; α-, β-, γ-,δ-sarcoglycans and sarcospans. These proteins provide a mechanical link between the extracellular matrix, via laminin binding, and the cytoskeleton, via F-actin binding. 4 This molecular bridge is thought to preserve the membrane integrity during mechanical stress. 5 The DGC is also involved in the maintenance of the normal cellular Ca 2+ gradient via the regulation of several proteins. 6, 7 In general, the absence of dystrophin increases the membrane fragility, either directly or indirectly.
This can be determined with a variety of experimental techniques and is often detected as an elevated stress-induced Ca 2+ influx from the extracellular space. 8 Generally, two distinct Ca 2+ influx pathways have been considered, both in skeletal muscle fibers and in cardiomyocytes. 1)
Localized microruptures of the sarcolemma result in abnormal stress-induced entry of Ca 2+ (and other ions) into the cells. 9,10 2) As mentioned above, loss of dystrophin seems to be responsible for the dysregulation of a number of proteins, such as stretch-activated channels (SACs), which constitute an alternative pathway for Ca 2+ entry into myocytes. 11, 12 SACs are nonselective cation channels with an increased activity triggered by mechanical stress. 13, 14 At present, the molecular identity of SACs is not known, and most likely there are several types of SACs expressed in skeletal and cardiac muscle. Some of the SACs are thought to contain ion channel proteins from the large family of transient receptor potential (TRP) channels, such as TRPV2 or TRPC1. Since preventing abnormal Ca 2+ influx via SACs could be a strategy to ameliorate dystrophy (and other diseases), there is considerable interest in the molecular underpinnings and functioning of these channels by guest on January 25, 2015
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In addition to enlarged Ca 2+ sarcolemmal influx, it has been observed that in dystrophic cardiomyocytes the entire Ca 2+ signaling system, in particular the Ca 15 This seems to result, at least partly, from post-translational modifications of the SR Ca 2+ release channels (a.k.a. ryanodine receptors, RyRs). As a consequence of all these Ca 2+ signaling disturbances, the resting cytosolic concentration was found to be slightly elevated in dystrophic cardiomyocytes. 13 In the present study we examined whether the transient receptor potential 
Methods

Cell isolation
All animal procedures conformed to the Guide for the Care and Use of Laboratory Protection Law (TSchG), and were carried out with permission by local Swiss authorities (permit BE126/12). C57BL/10 mice (4 months old), in the following referred to as wild-type (WT), and C57BL/10ScScn-mdx mice of identical age were provided by Profs. M. Rüegg (University Basel, Switzerland) and U. Rüegg (University Geneva, Switzerland) or purchased from Jackson Laboratory. Animals were euthanized by cervical dislocation, followed by rapid removal and enzymatic dissociation of the cardiac tissue as previously described.
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Immunocytochemistry
Cardiomyocytes were fixed with 4 % paraformaldehyde in PBS for 1 h, permeabilized with 0.5 % Triton X-100 in PBS for 1 h at room temperature. A blocking solution of 4 %, bovine serum albumin (BSA) was applied for 1 h. Cells were incubated overnight at 4 °C in a wet chamber with an anti-TRPV2 antibody against an extracellular epitope (1/100; Alomone ACC-039) and an anti-NCX antibody (1/100; Thermo Scientific MA3-926) diluted in PBS 4 %, BSA and 0.5 % Triton X-100. After washing out in PBS, cells were incubated for 2 h in PBS 4 % BSA and 0.5 % Triton X-100 with secondary antibodies (Alexa Fluor 488-conjugated goat antirabbit IgG and Alexa Fluor 568-conjugated donkey anti-mouse IgG; 1/100).
Experimental solutions
The isotonic superfusion solution contained (in mM): 140 NaCl, 5. Most chemicals were obtained from Sigma. Collagenase (type II) was purchased from Worthington, Di-8ANEPPS and fluo-3-AM from Biotium, tranilast from Cayman, thapsigargin and ryanodine from Alomone, 2-aminoethyl diphenylborinate (2-APB) and ruthenium red (RuR) from Fluka, TRPV2 and TRPC1 antibodies from Alomone (ACC-039 and ACC-032 for TRPV2
and ACC-118 for TRPC1). All experiments were performed at room temperature (20ºC).
Confocal microscopy
Examination of immunolabelled samples and Ca 2+ imaging were performed on an inverted laser-scanning confocal microscope (Olympus FV-1000) with a x60 water immersion objective (NA, 1.2). Cells were loaded with fluo-3-AM (5 μM) for 30 min and excited at 473 nm to record the fluorescence between 490 and 590 nm. Amplitude (F/F 0 ) and time-course of Ca 2+ transients were computed using ImageJ and Igor Pro software.
To label T-tubules, ventricular myocytes were incubated with 10 μM di-8-ANEPPS for 30 min. 12 After staining, the images of living cells were acquired with the confocal system. 
Biotinylation
Isolated cardiomyocytes were incubated with biotinylation reagent (Sulfo-NHS-LC-Biotin, APExBIO, 0.5 mg/ml in PBS) at 37ºC for 2 h. The biotin reagent was removed and cells were washed twice in cold PBS with 100 mM glycine and twice in cold PBS alone. Then, lysates were prepared and dosed as described above. 100 μg of each samples were incubated with 100 μl of streptavidin agarose resin (Thermo Scientific) for 16 hours at 4ºC to capture biotinylated proteins. The beads were pelleted and washed in lysis buffer. Captured proteins were eluted at 60ºC for 30 min with Laemmli 2X sample buffer containing 40 mg/mL of dithiothreitol. 
Cardiomyocyte culture and transfection
Isolated cardiomyocytes were cultured in Dulbecco"s modified Eagle"s medium (DMEM)
supplemented with insulin (10 mg/mL), HEPES (10 mM), NaHCO 3 (4 mM), blebbistatin (25 μM), cytochalasin D (0.5 μM). TRPV2 siRNA and non-targeting siRNA were obtained from
Origene. Transfection of siRNA was performed using GeneSilencer (Genlantis) for 4 h. 
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Subsequently, this medium was replaced by solution without transfection reagent for 20 h.
Lysates were prepared and dosed as described above.
Real-time Polymerase Chain Reaction
Total RNA from siRNA against TRPV2 and scrambled siRNA dystrophic cardiomyocytes were extracted using RNA purification kit (NucleoSpin RNA, Macherey-Nagel).
Mm_Trpv2_1_SG, Mm_Actb_1_SG were used as specific mouse RT-PCR primers (Qiagen).
The ACTB housekeeping gene (against β-actin) and TRPV2 gene were amplified in parallel.
Real-time RT-PCR was performed using 9 ng/μl of RNA (KAPA SYBR FAST One-Step 
Statistical analysis
All results are expressed as mean ± SEM of n observations. Sets of data were compared using Student"s t test, and significance is denoted as *P<0.05, **P<0.01. N refers to number of animals, n to number of cells.
Results
Osmotic stress induces abnormal Ca 2+ signals in dystrophic cardiomyocytes
As reported before, dystrophic muscle cells exhibit an abnormal membrane fragility and increased stretch sensitivity. 5, 17 We applied mild osmotic shocks to WT and dystrophic cardiomyocytes mimicking features of mechanical membrane stress during contractions (cell swelling by 15.8% in both, WT and mdx myocytes). 15 After 30 Accepted Manuscript the osmotic stress, visible as a transient decrease of fluorescence due to dye dilution ( Figure 1A and 1B). As described in previous studies, 15 cardiomyocytes from mdx mice displayed an increased fluorescence starting after a mild osmotic stress ( Figure 1B) . For quantitative analysis, 
Sarcolemmal TRPV2 localization and overexpression in mdx cardiomyocytes
In cultured dystrophic skeletal muscle myotubes, TRPV2 channels were found to be localized to the sarcolemma, where they mediated abnormal Ca 2+ influx from the extracellular space. 7, 17 In physiological conditions, TRPV2 channels are mainly localized to intracellular membrane structures, but are known to translocate to the plasma membrane upon specific stimulation, such as by insulin growth factor-1 (IGF-1). Once activated, they participate in the function and structure of cardiomyocytes. 21, 22 Therefore, we compared the TRPV2 expression and its subcellular distribution in freshly isolated WT and mdx cardiomyocytes ( Figure 2 ).
Comparative TRPV2 immunocytochemistry in WT cardiomyocytes showed only a staining within the cell (Figure 2A left above). In contrast, in mdx cells TRPV2 immunofluorescence displayed a strong localization at the sarcolemma and along the T-tubular network (Figure 2A left below). This specific localization was confirmed by a double staining against the Na + -Ca Accepted Manuscript exchanger (NCX) known to be expressed in the plasma membrane ( Figure 2A middle and left) . 23 Western blot analysis indicated a 2-fold TRPV2 overexpression in dystrophic myocytes ( Figure   2B ). The specific membrane bound fraction of TRPV2 was determined using a biotinylation assay, and normalized to GAPDH. The amount of TRPV2 at the plasma membrane was increased 1.6-fold compared to WT cells ( Figure 2C ).
Functional characterization of sarcolemmal TRPV2 channels
To assess the functional consequences of the membrane specific TRPV2 overexpression in mdx cardiomyocytes, we initially used pharmacological tools. TRP channel pharmacology is notoriously unspecific, but the TRPV2 channels have a peculiar pharmacological profile that sets them apart from many other TRP channels. Contrary to most TRP channels, they are not blocked by 2-APB, but become activated (albeit at a high 2-APB concentration of 500 µM). They are also activated by the organic anion transporter inhibitor probenecid (Pro, 1 mM). Ruthenium red (RuR, 40 µM) is an unspecific and tranilast (Tran, 1 mM) a somewhat more specific inhibitor of TRPV2 channel activity. [24] [25] [26] In order to experimentally examine Ca 2+ influx without interference from SR Ca 2+ release, mdx myocytes were preincubated with thapsigargin (Tg, 1 µM) and ryanodine (Rya, 10 µM) ( Figure 3A and 3B) . Subsequently, and prior to the actual experiment, several stimulations with caffeine (Caff, 10 mM) were applied to completely empty the SR.
Both, 2-APB and probenecid perfusions induced a Ca 2+ influx upon their application (F/F 0 of 1.39 ± 0.05 and 1.78 ± 0.1, respectively) ( Figure 3A and 3B 
Osmotic stress activates TRPV2 channels
To determine whether TRPV2 channels form part of SACs in dystrophic cardiac cells, mdx myocytes were exposed to stress in the presence of the TRPV2 inhibitor SKF96365 ( Figure 3C , left). Data obtained in WT and mdx myocytes is replotted from Figure 1 , for easier comparison. In additional experiments we applied the two TRPV2 inhibitors tranilast and RuR during the osmotic stress ( Figure 3D ). The Ca 2+ signal was 1.5-fold smaller in the presence of tranilast, and 1.6-fold in RuR (F/F 0Tran : 0.90 ± 0.01 and F/F 0RuR : 0.93 ± 0.01 compared to untreated mdx cells, 1.41 ± 0.09). These findings are consistent with an involvement of TRPV2 channels.
However, at present the TRPV2 pharmacology is not at all specific, as mentioned above.
To allow more specific conclusions regarding the role of TRPV2 channels and their identification as subunits of SACs we used a two-pronged approach: 1) block of the channel pore with antibodies and 2) ablation of TRPV2 with specific siRNA. First, to achieve specific inhibition of TRPV2 channels, mdx cardiomyocytes were incubated during 24 h with TRPV2
antibodies raised against an extracellular epitope, thereby blocking the pore to prevent cation influx ( Figure 4A) . 28 Cardiomyocytes kept in short term culture undergo substantial dedifferentiation, even after 24 h. The ends of cardiomyocytes round up and, most important for Another strategy to specifically remove the function of a particular protein is to interfere with its expression using siRNA ( Figure 5 ). To this end, mdx cardiomyocytes were incubated 4 h with siRNA directed against TRPV2 and maintained in culture during 24 h. 30 Transfected mdx cardiomyocytes were exposed to osmotic stress ( Figure 5A ). Ca Among several necessary control experiments, we verified successful transfection of siRNA into cardiac myocytes. Figure 5C shows cardiomyocytes which were incubated with fluorescently labeled siRNA, to verify siRNA transfection. In addition, siRNA transfection and TRPV2
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Accepted Manuscript silencing were validated by Western blot analysis and by quantitative RT-PCR ( Figure 5D ). In siRNA transfected cells, TRPV2 expression was decreased by 60% compared to the negative control (using scrambled siRNA). Figure 5E also highlights the integrity of the T-tubular network, as recorded with the fluorescent membrane dye di-8-ANEPPS. Taken together, these data provide strong evidence that siRNA mediated knockdown of TRPV2 normalized the stressinduced Ca 2+ handling in dystrophic cardiomyocytes.
Discussion
Dystrophin-deficient cardiomyocytes have an abnormally high membrane fragility making them sensitive to mechanical stress. 9 This loss of membrane integrity leads to an increased permeability which allows an abnormal stress-induced influx of extracellular Ca
2+
, presumably via SACs and membrane microruptures.
The two-hit hypothesis of dystrophic cardiomyopathy
Even though the lack of functional dystrophin protein has been identified as the cause for many forms of this disease, the mechanism(s) linking the absence of this cytoskeletal protein with the observed cellular damage remains poorly understood. Several versions of a "two-hit hypothesis" have been proposed as pathomechanisms of muscular dystrophies and dystrophic cardiomyopathies. 31 These hypotheses postulate a combined effect of abnormal Ca 2+ signals, both from sarcolemmal influx and SR leak, and oxidative stress. In normal muscle, the neuronal nitric oxide synthase (nNOS) is a member of the dystrophin-glycoprotein complex and localized at the sarcolemma. NO can protect cells from stronger oxidative damage by playing an antioxidant role, and by inhibiting NADPH oxidases, the major sources of reactive oxygen species (ROS). 32 In dystrophic myocytes, nNOS is down-regulated contributing to an enhanced generation of ROS. 33 In these cells the abnormal Ca 2+ influx and release further stimulate ROS production by mitochondria and NADPH oxidases, particularly after mechanical stress. 15 
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importance of these two mechanisms seems to change during the progression of the disease, with the SR leak becoming more and more prominent. 36 Overall, the two-hit mechanism creates an endless loop of abnormal Ca 2+ entry and oxidative damage that may culminate in activation of Ca 2+ dependent proteases and apoptotic or necrotic cell death. In principle, both mechanisms could offer multiple possibilities and targets for future pharmacological treatments.
Ca
2+ influx via stretch-activated membrane channels
In the present study we focused on one of the putative pathomechanism involved in influx. 47 It has been proposed that the translocation of TRPV2 could resemble that of glucose transporter 4 (GLUT4). GLUT4 is an insulin-regulated glucose transporter translocated from an intracellular storage to the plasma membrane upon insulin stimulation in adipocytes and in skeletal muscle fibers. Upon insulin growth factor-1 (IGF-1) stimulation, TRPV2 channels are targeted to the sarcolemma via the phosphatidylinositol 3-kinase (PI3K) pathways. 46, 48 Recently, new insight about this cation channels has been obtained in several pathological conditions. In dystrophic skeletal muscle fibers and myotubes in culture, TRPV2 channels were observed to be translocated from the intracellular space to the sarcolemma. 17, 20, 49, 50 In agreement with these observations, in our study, mdx cardiomyocytes displayed a strong TRPV2 localization at the sarcolemma and along the T-tubular network, when compared to WT cells. Moreover, we found that this abnormal translocation is accompanied by a TRPV2 overexpression, particularly at the sarcolemma, as suggested by biotinylation assays. Together, the elevated expression and translocation of TRPV2 channels in dystrophic cardiomyocytes are clearly consistent with their possible role in SACs and, further, suggest a stronger activity of TRPV2 in these cells.
TRPV2 as potential components of SACs is supported by unspecific TRP channel pharmacology
To assess the TRPV2 function at the plasma membrane of dystrophic myocytes, a pharmacological approach was used. As mentioned above, a known problem in the field of TRP channel research is the lack of highly specific pharmacological tools. 51 Furthermore, the efficiency of many compounds depends on the cell type and even the species. 47 In many cases, several unspecific compounds are used experimentally to block various TRP channels, such as ruthenium red, 2-APB, and SKF96365. For few channels some specific agonists are available, such as capsaicin for TRPV1 channels. Another promising strategy is to apply a compound that activates some TRP channels but blocks others. 2-APB, which is a blocker of many TRP by guest on January 25, 2015
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Accepted Manuscript channels, was the first activator identified for some TRPV channels, including TRPV2, in HEK293 cells. 47 Indeed, in our experiments with cardiomyocytes pretreated with thapsigargin and ryanodine (to eliminate SR function), the application of 2-APB elicited Ca 2+ influx from the extracellular space, that could be inhibited with ruthenium red. Consistent with a role of TRPV2
in Ca 2+ influx, the blocker SKF96365 also suppressed the stress induced Ca 2+ signals. 26 There are two pharmacological TRPV2 modulators, probenecid and tranilast (activator and inhibitor, respectively) that have been reported to exhibit somewhat better specificity for TRPV2 channels.
Probenecid was initially synthesized to reduce the renal excretion of antibiotics, particularly penicillin, and recently it has been identified as an agonist of TRPV2. 52, 53 Tranilast is clinically used as an antiallergic drug and experimentally as a TRPV2 antagonist. 46 Both compounds changed Ca 2+ influx in dystrophic myocytes with eliminated SR function in a way that was perfectly consistent with TRPV2 underlying this kind of influx. In summary, the analysis of the pharmacological profile revealed by our experiments allowed us to consider a pathological TRPV2 function in mdx cardiomyocytes.
Specific inhibition of TRPV2 protects dystrophic myocytes from abnormal
Ca
2+ signals
To specifically probe whether TRPV2 channels are responsible for the Ca 2+ increase after an osmotic shock in dystrophic myocytes, we applied an antibody raised against an extracellular epitope of the channel. If the channel pores are indeed blocked by these antibodies, this strategy suppresses the TRPV2 protein function and Ca 2+ can no longer enter the cytoplasm. However, the specificity of blocking antibodies has been challenged in different studies and may depend on a variety of parameters such as the type of experiments (Western blot, immunocytochemistry), species (rat, mouse), type of antibodies (polyclonal, monoclonal).
Therefore, we carried out several control experiments using other antibodies during the osmotic stress. As negative control experiments, we used antibodies raised against an intracellular epitope of the TRPV2 channel and against an extracellular epitope of TRPC1. In these experiments, we did not observe any inhibition of the TRPV2 function since the Ca 
Conclusion
Taken together, our observations indicate a major role of TRPV2 channels in the cardiac dystrophic Ca 2+ signaling pathology and provide compelling evidence that the TRPV2 proteins form a subunit of stretch activated channels.
TRPV2 channels and dystrophinopathies
Dystrophinopathies give rise to a wide spectrum of muscle diseases. Most forms include cardiac muscle participation. The most severe is DMD, characterized by the absence of dystrophin. Becker muscular dystrophy (BMD) results in a milder phenotype since dystrophin is produced but only partly functional. In X-linked cardiomyopathy (XLDCM), dystrophin is absent only in the cardiac muscle. These three dystrophinopathies all progress into a dilated cardiomyopathy. 54 As mentioned above, the two-hit hypothesis postulates a major pathological role for abnormal Ca 2+ influx across the sarcolemma as one of the main pathomechanisms. Our study reveals that TRPV2 proteins are abnormally recruited and activated in dystrophic cardiac myocytes. Thus, the TRPV2 proteins, their function and translocation pathway could be relevant targets for future pharmacological treatments of these and related pathologies. P44/P42 MAPK and GAPDH signals were obtained by reprobing after stripping, the TRPV2 band is contrast enhanced. Cardiomyocytes were isolated from N=4-7 mdx and WT mice. * P < 0.05, ** P < 0.01. 
